Franz Obermayr
Director Ejecutivo en Panoptes Pharma GmbH .
Cargos activos de Franz Obermayr
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Director Ejecutivo | 01/07/2013 | - |
| Fundador | 01/07/2013 | - |
Historial de carrera de Franz Obermayr
Antiguos cargos conocidos de Franz Obermayr.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director Ejecutivo | 01/02/2021 | 26/07/2021 |
| Director Técnico/Científico/I+D | 18/12/2020 | 31/12/2021 | |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01/01/2009 | 01/01/2013 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Austria | 2 |
| Irlanda | 2 |
Operativa
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorial
| Health Technology | 4 |
| Retail Trade | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
- Bolsa de valores
- Insiders
- Franz Obermayr
- Experiencia